Skip to content
Studies have shown that active fund managers routinely underperform the S&P500 index*
Home
Articles
WALL STREET X
Forecasts
Portfolios
Wall Street X
Articles
Forecasts
Portfolios
Search
Results for
{phrase}
(
{results_count}
of
{results_count_total}
)
Displaying
{results_count}
results of
{results_count_total}
Roivant Sciences Ltd. (NASDAQ: ROIV)
ROIV Stock Predictions and Ratings
WSX Rating:
STRONG SELL
WSX Forecast (1yr):
-99.90%
Analyst Rating:
STRONG BUY
Analyst Forecast (1yr):
14%
ROIV Stock Analysis
ROIV
PE Ratio:
ROIV
PEG Ratio:
Not Available
ROIV
Forward EPS Growth (12 month):
0.00%
ROIV
PS Ratio:
2499.2
ROIV
PSG Ratio:
Not Available
ROIV
Forward Revenue Growth (12 month):
0.00%
ROIV Articles
No data was found